Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: November 8, 2011
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2011.
Key Financial Metrics
The provided text is a cover report referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or details regarding material changes versus prior periods. It solely references the issuance of a press release containing these results.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It notes that the information in the report and exhibit is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 8, 2011) for actual financial figures.
- Verify specific revenue, net loss, and cash burn rates for the three and nine months ended September 30, 2011.
- Confirm the company's cash position and runway as of the reporting date.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the referenced press release.